Rare Disease

 (narith_2527/iStock via Getty Images Plus)

People on the Move: October 2020

By Jenni Spinner

The latest news on pharmaceutical industry hires, promotions, acquisitions and other events includes Medable, Eversana, Parexel, Astellas and more.

(Image: Getty/Chinnapong)

Rare disease trials create common burdens

By Jenni Spinner

In time for Rare Disease Day, orphan-disease patients, site managers and service providers discuss challenges obstacles faced in trial participation.

(Image: iStock/Hankimage9)

Ergomed to acquire orphan drug CRO for €5.7m

By Melissa Fassbender

Ergomed is bolstering its orphan drug development services with its acquisition of PSR Group BV in a deal worth up to €5.7m ($6.69m) – which will position the company to be a “global player” in the area, says CEO.


Follow us


View more


Featured Suppliers